DiRROS repository (University of Maribor)· 2020· Clinical trial
Dexamethasone in Hospitalized Patients with Covid-19.
- 8,046citations
- 2020year
Short summary
Dexamethasone significantly reduced 28-day mortality by 17% in hospitalized COVID-19 patients requiring respiratory support, but showed no benefit for those not needing oxygen.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Infectious Diseases
Infectious DiseasesMedicine